Literature DB >> 2448091

Characterization of a carbocyanine derivative as a fluorescent penetration probe.

P L Olive1, R E Durand.   

Abstract

The fluorescent carbocyanine dye 3,3-diheptyloxycarbocyanine [DiOC7(3)], originally described as a membrane potential probe, penetrates poorly into multicell spheroids. Since the dye is retained in the cells following spheroid disaggregation, cells can be selected from different depths within the spheroid using fluorescence-activated cell sorting. Characterization of the binding kinetics, stability, and toxicity of this probe were undertaken, and intercompared with Hoechst 33342. The optimum drug dose for achieving good separation of internal and external cells of spheroids is about tenfold lower than for Hoechst 33342, and like Hoechst, DiOC7(3) is toxic at concentrations at least tenfold higher than those required to produce a good gradient for cell separation. When cells are removed from the stain, cellular fluorescence decreases to half the initial intensity within 2 hours; however, unlike Hoechst, the carbocyanine dye does not transfer between cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448091     DOI: 10.1002/cyto.990080607

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  4 in total

1.  Use of a carbocyanine dye as a marker of functional vasculature in murine tumours.

Authors:  M J Trotter; D J Chaplin; P L Olive
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

2.  Hydroethidine: a fluorescent redox probe for locating hypoxic cells in spheroids and murine tumours.

Authors:  P L Olive
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

3.  Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse.

Authors:  M J Trotter; P L Olive; D J Chaplin
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

4.  Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements.

Authors:  B M Fenton; S F Paoni; J Lee; C J Koch; E M Lord
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.